International Clinical Trial: Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy(R) XR Extended Release Film Coated Tablets

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213895) titled 'Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy(R) XR Extended Release Film Coated Tablets' on Oct. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Humanis Saglik Anonim Sirketi

Condition: Type 2 Diabetes Mellitus (T2DM)

Intervention: Drug: Empagliflozin/Linagliptin/Metformin HCL

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: May 21, 2025

Target Sample Size: 14

Coun...